First-Line RCC Treatment Cleared in Sunitinib Labeling
New labeling of Sutent (sunitinib malate, Pfizer) has been approved that includes first-line treatment of advanced renal cell carcinoma (RCC).
Print Issue: April 01, 2007
What Constitutes Locally Advanced PCa?
The most widespread nondermatologic malignancy in men, prostate cancer afflicts one in six American males and kills one in 34. Growing public awareness, an aging population, and increased PSA screening has led to greater detection of early-stage disease.
New Oral Treatment for High BP Approved
FDA has announced the approval of Tekturna (aliskiren) tablets for hypertension, both as monotherapy or in combination with other high-BP medications.
Vasectomies May Cause Brain Damage
Vasectomy may be a risk factor for primary progressive aphasia (PPA) in men, say researchers at Northwestern University Feinberg School of Medicine in Chicago.
PSA Velocity Threshold is Too High
ORLANDO—New findings presented here suggest clinicians should use a lower PSA velocity (PSAV) to recommend prostate biopsies in men who have PSA levels less than 4 ng/mL.
Urine Test May Improve PCa Diagnosis
ORLANDO—A urine assay for prostate cancer gene 3 (PCA3) is superior to serum PSA tests for predicting outcomes of repeat prostate biopsy, data show.
Primary Screening in Renal Patients
The medical care care of patients with renal disease includes notonly disease-specific care but preventive and general care as well as the treatment of minor acute illnesses, according to Kevin M. Fosnocht, MD, clinical assistant professor of medicine at the University of Pennsylvania School of Medicine in Philadelphia.
Ureteral Stone Treatments Comparable
Extracorporeal shock wave lithotripsy (ESWL) and ureteroscopy are both safe and effective for removing ureteral stones, and neither is clearly superior to the other, according to a meta-analysis of randomized controlled studies.
Post-Tx Diabetes Risks Characterized
Risk factors for new-onset diabetes after renal transplantation include tacrolimus immunosuppression and older age and heavier weight at the time of transplantation.
Taking Fewer Lanthanum Carbonate Pills
SAN DIEGO—Doses of lanthanum carbonate as high as 4,500 mg a day appear to be well tolerated and may provide serum phosphorus control for some stage-5 CKD patients who do not respond to 3,000 mg a day, according to a new trial of patients on maintenance hemodialysis.
- Loading...
Loading...
Loading... 
Loading...